These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 581016)
21. [Correlations between PRL and 17-beta-E in human breast cancer]. Larrad Jiménez A; Ruiz-Tartas A; Zapatero Gaviria J; López Lazareno N Rev Esp Oncol; 1984; 31(2):279-87. PubMed ID: 6549590 [TBL] [Abstract][Full Text] [Related]
22. [Buprenorphine in cancer pain: cross comparison with pentazocine]. De Conno F; Ripamonti C; Tamburini M; Ventafridda V Minerva Med; 1987 Aug; 78(15):1177-81. PubMed ID: 3302764 [TBL] [Abstract][Full Text] [Related]
23. Prolactin concentrations in patients with breast cancer. Franks S; Ralphs DN; Seagroatt V; Jacobs HS Br Med J; 1974 Nov; 4(5940):320-1. PubMed ID: 4434088 [TBL] [Abstract][Full Text] [Related]
24. [Serum levels of prolactin, estradiol, testosterone and sex hormone-binding globulin in women with breast cancer treated with cytostatics and anti-estrogens]. Grodecka-Gazdecka S; Baron J Ginekol Pol; 1986 Dec; 57(12):778-83. PubMed ID: 3570023 [No Abstract] [Full Text] [Related]
25. Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer. Frontini L; Lissoni P; Vaghi M; Perego MS; Pescia S; Ardizzoia A; Gardani G Anticancer Res; 2004; 24(6):4223-6. PubMed ID: 15736476 [TBL] [Abstract][Full Text] [Related]
26. [Prolactin and estradiol levels during hormone therapy of breast cancer]. Grodecka-Gazdecka S; Chwalisz K; Baron J Ginekol Pol; 1985 Apr; 56(4):195-201. PubMed ID: 4043797 [No Abstract] [Full Text] [Related]
27. Plasma prolactin responses to thyrotropin-releasing hormone in patients with breast cancer. Ohgo S; Kato Y; Chihara K; Imura H Cancer; 1976 Mar; 37(3):1412-6. PubMed ID: 816451 [TBL] [Abstract][Full Text] [Related]
28. Intravenous infusion of beta-endorphin increases serum prolactin, but not growth hormone or cortisol, in depressed subjects and withdrawing methadone addicts. Catlin DH; Poland RE; Gorelick DA; Gerner RH; Hui KK; Rubin RT; Li CH J Clin Endocrinol Metab; 1980 Jun; 50(6):1021-5. PubMed ID: 7372783 [TBL] [Abstract][Full Text] [Related]
29. [Relationship between benign breast cancer and plasma levels of prolactin]. Strollo F; Perniciaro G; Di Cesare T; Morè M; Marini R; Riondino G Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2338-44. PubMed ID: 7337747 [TBL] [Abstract][Full Text] [Related]
30. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay. Rose DP; Berke B; Cohen LA Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857 [TBL] [Abstract][Full Text] [Related]
31. Methadone-maintained patients. Effect of methadone on plasma testosterone, FSH, LH, and prolactin. Cushman P; Kreek MJ N Y State J Med; 1974 Oct; 74(11):1970-3. PubMed ID: 4528642 [TBL] [Abstract][Full Text] [Related]
32. Plasma prolactin and breast cancer. Wilson RG; Buchan R; Roberts MM; Forrest AP; Boyns AR; Cole EN; Griffiths K Cancer; 1974 May; 33(5):1325-7. PubMed ID: 4823482 [No Abstract] [Full Text] [Related]
33. Methadone for the pentazocine-dependent patient. Raskin NN N Engl J Med; 1970 Dec; 283(24):1349. PubMed ID: 5478464 [No Abstract] [Full Text] [Related]
34. Chronic analgesic study on buprenorphine action in cancer pain. Comparison with pentazocine. Ventafridda V; De Conno F; Guarise G; Tamburini M; Savio G Arzneimittelforschung; 1983; 33(4):587-90. PubMed ID: 6683540 [TBL] [Abstract][Full Text] [Related]
35. A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines. Lissoni P; Bucovec R; Malugani F; Ardizzoia A; Villa S; Gardani GS; Vaghi M; Tancini G Anticancer Res; 2002; 22(2B):1131-4. PubMed ID: 12168912 [TBL] [Abstract][Full Text] [Related]
36. Circulating levels of prolactin in human breast cancer. Sheth NA; Ranadive KJ; Suraiya JN; Sheth AR Br J Cancer; 1975 Aug; 32(2):160-7. PubMed ID: 2274 [TBL] [Abstract][Full Text] [Related]
37. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma]. Pavić S; Pavić Z Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335 [TBL] [Abstract][Full Text] [Related]
38. Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression. Levin PA; Malarkey WB J Clin Endocrinol Metab; 1981 Jul; 53(1):179-83. PubMed ID: 7240375 [No Abstract] [Full Text] [Related]
39. Sexual Dysfunction in Men Receiving Methadone Maintenance Treatment: Clinical History and Psychobiological Correlates. Gerra G; Manfredini M; Somaini L; Maremmani I; Leonardi C; Donnini C Eur Addict Res; 2016; 22(3):163-75. PubMed ID: 26595117 [TBL] [Abstract][Full Text] [Related]
40. Importance of serum prolactin determination in metastatic breast cancer patients. Mujagić Z; Mujagić H Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]